Press release
Investigation announced for Investors in shares of Zoetis Inc. (NYSE: ZTS) over possible Violations of Securities Laws
An investigation for investors in Zoetis Inc. (NYSE: ZTS) shares over potential securities laws violations by Zoetis Inc.
Investors who purchased shares of Zoetis Inc. (NYSE: ZTS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Zoetis Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Parsippany, NJ based Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. Zoetis Inc. Reported that its annual Total Revenue rose from over $8.08 billion in 2022 to over $8.54 billion in 2023, and that its Net Income increased from over $2.11 billion in in 2022 to over $2.34 billion in 2023.
On April 12, 2024, The Wall Street Journal released a shocking report detailing the alarming number of adverse events associated with the animal osteoarthritis pain medications Librela and Solensia, manufactured by Zoetis.
Shares of Zoetis Inc. (NYSE: ZTS) declined from $198.22 per share in February 2024, to as low as $148.48 per share on April 12, 2024.
Those who purchased shares of Zoetis Inc. (NYSE: ZTS) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Zoetis Inc. (NYSE: ZTS) over possible Violations of Securities Laws here
News-ID: 3465061 • Views: …
More Releases from Shareholders Foundation, Inc.
Fiserv, Inc. (NYSE: FI) Investor Alert: Deadline in Lawsuit on September 22, 202 …
A deadline is coming up on September 22, 2025 in the lawsuit filed for certain investors of Fiserv, Inc. (NYSE: FI) over alleged securities laws violations by Fiserv, Inc.
Investors who purchased shares of Fiserv, Inc. (NYSE: FI) have certain options and there are strict and short deadlines running. Deadline: September 22, 2025. Fiserv, Inc. (NYSE: FI) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
Investigation announced for Long-Term Investors in Rocket Pharmaceuticals, Inc. …
An investigation was announced for current long-term investors in shares of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) concerning potential breaches of fiduciary duties by certain directors of Rocket Pharmaceuticals, Inc..
Investors who are current long term investors in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
Lawsuit filed for Investors who lost money with shares of LifeMD, Inc. (NASDAQ: …
An investor, who purchased shares of LifeMD, Inc. (NASDAQ: LFMD), filed a lawsuit over alleged violations of Federal Securities Laws by LifeMD, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and for certain investors are short and strict deadlines running. Deadline: October 27, 2025. NASDAQ: LFMD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Alto Neuroscience, Inc. (NYSE: ANRO) Investor Alert: Deadline in Lawsuit on Sept …
A deadline is coming up on September 19, 2025 in the lawsuit filed for certain investors of Alto Neuroscience, Inc. (NYSE: ANRO) over alleged securities laws violations by Alto Neuroscience, Inc.
Investors who purchased shares of Alto Neuroscience, Inc. (NYSE: ANRO) have certain options and there are strict and short deadlines running. Deadline: September 19, 2025. Alto Neuroscience, Inc. (NYSE: ANRO) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or…
More Releases for Zoetis
Veterinary Vaccines Market Insights, Forecast to 2031 Zoetis, Pfizer.
A new Report by DataM Intelligence, titled "Veterinary Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Veterinary Vaccines market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Veterinary Vaccines market has…
Microfluidics Market Size to Reach USD 1028.8 million by 2028 | Zoetis, PerkinEl …
The latest report on Microfluidics Market highlights the elements enhancing the developmental scope of the market as well as inhibitors challenging its growth during the forecast period. The study presents information on market segments in terms of product terrain, structure outlook, and distribution channel.
For More Details on This Report @ https://www.marketstudyreport.com/reports/global-microfluidics-market-research-report-2023
Global Microfluidics Market Size was estimated at USD 776.6 million in 2022 and is projected to reach USD…
Dexmedetomidine Market to See Booming Growth | Pfizer, Zoetis, Vetoquinol
The latest study released on the Global Dexmedetomidine Market by AMA Research evaluates market size, trend, and forecast to 2027. The Dexmedetomidine market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This Report…
Spectinomycin (CAS 1695-77-8) Market to Witness Huge Growth by Key Players: Luka …
The Spectinomycin (CAS 1695-77-8) research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Spectinomycin (CAS 1695-77-8) research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Download FREE Sample Report…
Mammal Antibiotics Market Worth Observing Growth | Bayer, Zoetis, Dechra Pharmac …
The latest analysis released by HTF MI on "Global Mammal Antibiotics Market Outlook 2020 Survey results" sheds light on how investment and competitive landscape is impacted due to significant changes in the Mammal Antibiotics Industry. The research coverage includes analysis on companies such as Boehringer Ingelheim GmbH, Bayer AG, Zoetis, Dechra Pharmaceuticals PLC, Virbac, Merck, Vetoquinol S.A., Eli Lilly and Company, Ceva Sante Animale & Sanofi etc. It is expected…
Animal Drugs Market Is Booming Worldwide |Zoetis, Boehringer Ingelheim, Bayer
HTF MI newly added the Global Animal Drugs Market Study that gives meticulous investigation of current scenario of the Market size, share, demand, growth, trends, and forecast in the coming years.
The report firstly introduced the Animal Drugs Market basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world main region market conditions, including the product price, profit,…
